Reusability Report: Few-shot learning creates predictive models of drug response that translate from high-throughput screens to individual patients
So, E.; Yu, F.; Wang, B.; Haibe-Kains, B.
Show abstract
Machine learning (ML) and artificial intelligence (AI) methods are increasingly used in personalized medicine, including precision oncology. Ma et al. (Nature Cancer 2021) developed a new method c alled "Transfer of Cell Line Response Prediction" (TCRP) to train predictors of drug response in cancer cell lines and optimize their performance in higher complex cancer model systems via few-shot learning. TCRP was presented as a successful modeling approach in multiple case studies. Given the importance of this approach to assist clinicians in their treatment decision process, we sought to reproduce independently the authors findings and improve the reusability of TCRP in new case studies, including validation in clinical trial datasets, a high bar for drug response prediction. Our results support the superiority of TCRP over established statistical and machine learning approaches in preclinical and clinical settings. We developed new resources to increase the reusability of the TCRP model for future improvements and validation studies.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- NCT Precision Oncology Thesaurus Drugs – a Curated Database for Drugs, Drug Classes, and Drug Targets in Precision Cancer Medicine 94%
- Exploring Integrative Analysis using the BioMedical Evidence Graph 93%
- Histology-based Prediction of Therapy Response to Neoadjuvant Chemotherapy for Esophageal and Esophagogastric Junction Adenocarcinomas Using Deep Learning 92%
Similar papers in this journal
- Network-based estimation of therapeutic efficacy and adverse reaction potential for prioritisation of anti-cancer drug combinations 95%
- Artemis: Harnessing Knowledge Graphs for Next-Generation Drug Target Prioritization 95%
- G-PLIP: Knowledge graph neural network for structure-free protein-ligand bioactivity prediction 93%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.